✦ LIBER ✦

Lung cancer mortality risk among breast cancer patients treated with anti-estrogens

✍ Scribed by Christine Bouchardy; Simone Benhamou; Robin Schaffar; Helena M. Verkooijen; Gerald Fioretta; Hyma Schubert; Vincent Vinh-Hung; Jean-Charles Soria; Georges Vlastos; Elisabetta Rapiti

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 137 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25638

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of early recurrence among postmenop

Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen

✍ Hagen Kennecke; Heather McArthur; Ivo A. Olivotto; Caroline Speers; Chris Bajdik 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 1 views

## Abstract ## BACKGROUND Adjuvant aromatase inhibitors (AIs), instead of or after tamoxifen, are effective in decreasing recurrence in postmenopausal women with estrogen receptor (ER)‐positive breast cancer. An understanding of which patients are at risk of early recurrence while they are receivi

Risk of hypothyroidism in older breast c

Risk of hypothyroidism in older breast cancer patients treated with radiation

✍ Grace L. Smith; Benjamin D. Smith; Sharon H. Giordano; Ya Chen T. Shih; Wendy A. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 2 views

## Abstract ## BACKGROUND. Hypothyroidism is a potential complication after radiation therapy (RT) when treatment fields include the thyroid. The authors assessed risk of hypothyroidism in breast cancer patients who were receiving RT to a supraclavicular field, which typically includes a portion o

Concurrent lobular neoplasia increases t

Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy

✍ Udo Rudloff; Edi Brogi; Julia P. Brockway; Jessica I. Goldberg; Milicent Cranor; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 428 KB 👁 2 views

Monitoring of disseminated tumor cells i

Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy

✍ Vilde Drageset; Jahn M. Nesland; Bjorn Erikstein; Eva Skovlund; Hilde Sommer; Gu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 139 KB 👁 1 views

## Abstract The present study aimed to investigate the clinical relevance of disseminated tumor cells (DTC) in breast cancer patients before and after high‐dose adjuvant chemotherapy with or without progenitor stem‐cell support. One hundred and eighteen high‐risk stage II breast cancer patients ent

Akt is frequently activated in HER2/neu-

Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients

✍ Eriko Tokunaga; Yasue Kimura; Eiji Oki; Naoyuki Ueda; Motonori Futatsugi; Kojiro 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 284 KB

Akt/PKB is a serine/threonine kinase that plays an important role in survival when cells are exposed to different apoptotic stimuli. Aberrant activation of Akt/PKB in breast carcinoma is associated with poor prognosis and resistance to endocrine therapy and chemotherapy. The Akt signaling pathway cu

Cancer risk in patients with rheumatoid

Cancer risk in patients with rheumatoid arthritis treated with anti–tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?

✍ Johan Askling; Ronald F. van Vollenhoven; Fredrik Granath; Pauline Raaschou; C. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 3 views